Paula
Rodríguez Otero
Consultora Médica
New York University Langone Medical Center
Nueva York, Estados UnidosPublications en collaboration avec des chercheurs de New York University Langone Medical Center (3)
2023
2021
-
Matching adjusted indirect comparisons of efficacy outcomes for idecabtagene vicleucel (ide-cel, bb2121) versus selinexor + dexamethasone and belantamab mafodotin in relapsed and refractory multiple myeloma
Leukemia and Lymphoma, Vol. 62, Núm. 10, pp. 2482-2491
-
Treatment Patterns and Outcomes in Triple-Class Exposed Patients With Relapsed and Refractory Multiple Myeloma: Findings From the Multinational ITEMISE Study
Clinical Therapeutics, Vol. 43, Núm. 11, pp. 1983-1996.e3